A phase II study of PTX 9908 for the treatment of liver cancer.
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2016
At a glance
- Drugs PTX 9908 (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Feb 2016 New trial record
- 17 Dec 2014 According to a TCM Biotech media release, the company plans to apply for phase II clinical trials in Taiwan in the first half of 2015.